Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Centre for Diabetes, Endocrinology and Metabolism

OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.

Head of OCDEM

Fredrik Karpe

Professor of Metabolic Medicine

fredrik.karpe@ocdem.ox.ac.uk

+44 (0)1865 857222

The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit, specialising in performing national and multinational clinical trials related to diabetes.

© Martin Phelps

Diabetes Trials Unit

The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit, specialising in performing national and multinational clinical trials related to diabetes.

Read more

Scientists at the University of Oxford have identified a gene that in women is linked to the creation and location of new fat cells and in turn contributes to an increased risk of type 2 diabetes.

Gene that contributes to female body shape may increase risk of type 2 diabetes

Scientists at the University of Oxford have identified a gene that in women is linked to the creation and location of new fat cells and in turn contributes to an increased risk of type 2 diabetes.

Read more

The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases.

About OCDEM

The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases.

Read more

Seminars and Events

Glycaemia and thrombosis in diabetes: The role of the fibrin network

Wednesday, 23 January 2019, 1pm to 2pm
Bedside to bench and back for pituitary adenomas

Wednesday, 30 January 2019, 1pm to 2pm
Beta cell development, heterogeneity and regeneration

Wednesday, 06 February 2019, 1pm to 2pm
Title TBC

Tuesday, 12 February 2019, 1pm to 2pm
Title TBC

Wednesday, 13 February 2019, 1pm to 2pm

Latest Publications

δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.

Briant LJB. et al, (2018), J physiol, 596, 197 - 215
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

Mentz RJ. et al, (2017), Am heart j, 187, 1 - 9
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Holman RR. et al, (2017), Lancet diabetes endocrinol, 5, 877 - 886
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.

Howles SA. et al, (2017), Jci insight, 2

Latest News

Professor Leanne Hodson delivers the Starling Medal lecture

20 November 2018
Uncovering the full story in diabetes

14 November 2018
RDM at IF festival

22 October 2018
Congratulations to our new Professors

7 August 2018

Read more

OCDEM Vacancies

Events

View previous and upcoming events in OCDEM.

Find out more